BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 8, 2007
View Archived Issues
N-Acetylcysteine to be evaluated in clinical study for the treatment of rhabdomyolysis
Read More
Carraguard vaginal gel acceptable to healthy Thai couples
Read More
AMG-531 increases platelet counts in immune thrombocytopenic purpura patients
Read More
CoGenesys files to conduct clinical studies of Neugranin in Europe
Read More
Viprovex studied for adjuvant utility in pandemic influenza
Read More
Phase II trial to examine A-002 in coronary atherosclerosis patients
Read More
Oscient grants Factive European commercialization rights to Menarini
Read More
Alkermes and Indevus collaborate to develop inhaled trospium chloride for COPD
Read More
BSI-201 studied with cytotoxic regimens for solid tumors
Read More
Elusys and Pfizer to develop new therapeutics based on HP Antibody technology
Read More
Inspire updates progress in dry eye program
Read More
Pluristem submits pre-IND document for PLX-I
Read More
Victory Pharma's IND cleared for MGX-006
Read More
Raven and Wyeth enter monoclonal antibody agreement
Read More
SPI-1005 completes phase I testing for noise-induced hearing loss
Read More
Sunesis outlicenses LFA-1 inhibitor program to SARcode
Read More
Aveo acquires license to VEGF receptor inhibitor KRN-951
Read More
Immune Response receives milestone payment from NovaRx
Read More
Boston Life Sciences acquires rights to develop and commercialize Cethrin
Read More
New analgesic agents described in recent patents
Read More
Horizon raises funds to support phase III program for HZT-501
Read More
Novel agents for cardiovascular disorders claimed
Read More
Recent patents reveal discovery of novel antidiabetic agents
Read More
Cerepro phase III trial progresses
Read More
Pharmacopeia and Wyeth to develop JAK3 inhibitor products
Read More
Positive findings for pertuzumab plus gemcitabine in phase II trial
Read More